Testicular germ cell tumours in Iceland

APMIS

Volumn 114, Issue 11, 2006, Pages 779-783

  Agnarsson, Bjarni A ^a,c   Gudbjartsson, Tomas ^a   Einarsson, Gudmundur Vikar ^a,c   Magnusson, Kjartan ^a   Thoroddsen, Asgeir ^a   Bergthorsson, Jon Thor ^a,b   Amundadottir, Laufey ^b   Barkardottir, Rosa B ^a   Björnsson, Johannes ^a,c  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b DECODE GENETICS   (Iceland)

^c UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Epidemiology; Germ cell tumours; Pathology; Staging; Testicular tumours

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CLINICAL STUDY; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ICELAND; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; SEMINOMA; TERATOMA; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; YOLK SAC TUMOR;

ADULT; CHILD, PRESCHOOL; HUMANS; ICELAND; INCIDENCE; MALE; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS;

EID: 33750537791     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2006.apm_468.x     Document Type: Article

References (25)

1. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol 2003;170:5-11.
2. Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: an overview. Int J Cancer 2005;116:331-9.
3. Mickisch GHJ. Prognostic parameters for the management of advanced testis tumours. Curr Opin Urol 2000;10:465-71.
4. Gori S, Porrozzi S, Roila F, Gatta G, De Giorgi U, Marangolo M. Germ cell tumours of the testis. Crit Rev Oncol Hematol 2005;53:141-64.
5. Gudbjartsson T, Magnusson K, Bergthorsson J, Barkardottir RB, Agnarsson BA, Thoroddsen A, et al. A population-based analysis of increased incidence and improved survival of testicular cancer patients in Iceland. Scand J Urol Nephrol 2003;37:292-8.
6. Lawton AJ, Mead GM. Staging and prognostic factors in testicular cancer. Semin Surg Oncol 1999;17:223-9.
7. Van Brussel JP, Mickisch GHJ. Prognostic factors in prostate and testis cancer. BJU Int 1999;83:910-7.
8. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2004.
9. Bergthorsson JT, Agnarsson BA, Gudbjartsson T, Magnusson K, Thoroddsen A, Palsson B, et al. A genome-wide study of allelic imbalance in human testicular germ cell tumours using microsatellite markers. Cancer Genet Cytogenet 2006;164:1-9.
10. Gudlaugsson E, Magnusson B, Hallgrimsson J. Tumours in Iceland. 13. Malignant tumours of the testis. A histological classification, epidemiological considerations and survival. APMIS 1990;98:173-8.
11. Richiardi L, Bellocco, Adami HO, Torrang A, Barlow L, Hakulinen T, et al. Testicular cancer incidence in eight Northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 2004;13:2157-66.
12. Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA. International patterns and trends in testis cancer incidence. Int J Cancer 2005;115:822-7.
13. Heimdal K, Olsson H, Tretli S, Flodgren P, Borresen AL, Fossa SD. Risk of cancer in relatives of testicular cancer patients. Br J Cancer 1996;73:970-3.
14. Sonneveld DJ, Sleijfer DT, Schrafford Koops H, Sijmons RH, vand der Graaf WT, Sluiter WJ, et al. Familial testicular cancer in a single-centre population. Eur J Cancer 1999;35:1368-73.
15. Bromen K, Stang A, Baumgardt-Elms C, Stegmaier C, Ahrens W, Metz KA, et al. Testicular, other genital, and breast cancers in first-degree relatives of testicular cancer patients. Cancer Epidermiol Biomarkers Prev 2004;13:1316-24.
16. McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 2003;97:63-70.
17. von Hochstetter AR, Hedinger CE. The differential diagnosis of testicular germ cell tumors in theory and practice. A critical analysis of two major systems of classification and review of 389 cases. Virchows Arch A Pathol Anat Histol 1982;396:247-77.
18. Krag Jacobsen G, Barlebo H, Olsen J, Schultz HP, Starklint H, Sögaard H, et al. Testicular germ cell tumours in Denmark 1976-1980. Pathology of 1058 consecutive cases. Acta Radiologica Oncologica 1984;23:239-47.
19. Cheville JC. Classification and pathology of testicular germ cell and sex cord-stromal tumors. Urol Clinics North America 1999;26:595-609.
20. Mostofi FK, Sesterhenn IA, Davis CJ. Developments in histopathology of testicular germ cell tumors. Semin Urol 1988;6:171-88.
21. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. New Engl J Med 1997;337:242-53.
22. Sonneveld DJ, Hoekstra HJ, Van der Graaf WT, Sluiter WJ, Schraffordt Koops H, Sleijfer DT. The changing distribution of stage in nonseminomatous testicular germ cell tumours, from 1977 to 1996. BJU Int 1999;84:68-74.
23. Powles TB, Bhardwa J, Shamash J, Mandalia S, Oliver T. The changing presentation of germ cell tumours of the testis between 1983 and 2002. BJU Int 2005;95:1197-200.
24. Foster RS. Testicular cancer: what's new in staging, prognosis and therapy. Oncology 1999;13:1689-94.
25. Vergouwe Y, Steyerberg EW, Eijkemans MJC, Albers P, Habbema JDF. Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review. J Clin Oncol 2003;21:4092-9.